Category: Law & Society

  • Should Paternity Tests Be Mandatory at Birth? Cast Your Vote

    Should every baby get a paternity test at birth, automatically? Some say it protects fathers, mothers, and children from years of doubt. Others say it’s a question of privacy, trust, and who gets to decide. We want to hear where you stand.

    Voting is anonymous. Once you vote, you’ll see how everyone else has voted so far.

    Step 1: Cast your vote

    Step 2: Tell us why (optional)

    No name or email needed.

    ← Back

    Thank you for your response. ✨

    Thank you. Your reason was recorded anonymously.
    How did you vote?(required)

    Want the background first? Read DNA Testing vs. Marriage.

  • They “Give” You a Voice — Here’s What That Actually Means

    They “Give” You a Voice — Here’s What That Actually Means

    Every so often the government proposes a new rule. Could be about your neighborhood, your money, your health, your rights. And somewhere in the fine print of how this country works, there’s a process called the Public Comment Period — a window, usually 30 to 60 days, where you can officially respond.

    They call it participation.

    Read it closer.

    Agencies are required to read significant comments. They are required to respond to them in writing. But they are not required to change anything. Not one word. A well-reasoned comment could give them every argument they need to justify doing exactly what they were already going to do — just with better paperwork.

    That’s not cynicism. That’s the document.

    So why share it? Because knowing the difference between a right and a guarantee matters. Because silence hands them even more. And because if you’re going to engage the system, you should walk in clear-eyed — not sold a dream.

    Here’s the tool. Here’s how it works. What you do with that is yours.


    “YOUR VOICE ON RECORD” — A PUBLIC COMMENT GUIDE

    Not a guarantee. Not a magic fix. Just the process — laid out plain.

    What Is a Public Comment?

    When a federal agency wants to create or change a rule, they are legally required to open a public comment period before finalizing it. Anyone can submit a comment. No degree, no title, no connections required.

    What happens after? That’s their call.


    Step 1 — Find the Rule

    Go to federalregister.gov or regulations.gov
    Search by topic, keyword, or agency name.
    Look for anything marked “Proposed Rule” or “Notice of Proposed Rulemaking.”
    Check the deadline — late comments may not be considered at all.


    Step 2 — Write Your Comment

    Use this as your starting point:

    INTRODUCTION
    Who are you and why does this rule affect you specifically?
    “I am a [description] in [location]. This proposed rule directly impacts me because…”

    BACKGROUND
    Which part of the rule are you addressing? Name it specifically.
    “I am commenting on the section that proposes…”

    YOUR ANALYSIS
    How does this affect you, your community, your livelihood? What did they miss? What could go wrong that they haven’t accounted for?

    YOUR RECOMMENDATION
    What should change and why? Be specific. Vague opposition carries little weight — and even specific opposition isn’t guaranteed to either.

    CONCLUSION
    Two or three sentences. Main point. What you want them to do.


    Step 3 — Submit It

    federalregister.gov — click “Submit a Formal Comment” directly on the rule’s page.
    regulations.gov — search the docket number, find the rule, click “Comment.”


    What You Should Know Going In

    • They have to read it. They don’t have to act on it.
    • A flood of identical copy-paste comments carries almost no weight.
    • A detailed, specific, experience-based comment carries more — and can still be used to strengthen their case.
    • The public comment process is not a vote. Numbers don’t decide the outcome.
    • Your comment becomes part of the official record. That matters — even if the outcome doesn’t change today.

    The Bottom Line

    This is a door they built into the system. It’s real. Walking through it puts you on record — and that has its own kind of value. But know what you’re walking into.

    A right is not the same as power. Not always.

    Use the tool. Understand the tool. And keep building from there.


    Document Source: “How You Can Effectively Participate in the Regulatory Process Through Public Comment” — Office of Management and Budget

  • What If God Is a Woman? (I Wasn’t Ready for That Question)

    I wasn’t asked this question in a classroom. Nobody handed me a study guide. I got hit with it the way you get hit with something real — mid-conversation, no warm-up, by somebody who clearly had been sitting with this longer than I had.

    “What if God is a woman?”

    My first reaction? Honestly — resistance. Not because I thought the idea was wrong, but because nobody had ever put it to me that directly before. We don’t talk about God like that where I come from. You learn a name, you learn a pronoun, and you repeat it for the rest of your life without ever stopping to ask why.

    But here’s the thing about a question you can’t dismiss — it follows you. And this one followed me.

    The Part That Made Me Stop

    The argument wasn’t what I expected. It wasn’t about politics or equality or pushing an agenda. It started with something that felt almost too simple:

    Every human being — every single one — carries both a masculine and feminine aspect within their personality.

    And I thought about that. A man who can be fierce and tender. A woman who can be nurturing and immovable. None of us are all one thing. We contain both. So if creation itself contains both — if we were made in the image of whatever God is — then why have we spent thousands of years insisting that image only looks one way?

    That’s not a political question. That’s a philosophical one. And once I sat with it honestly, I couldn’t unfeel it.

    What Life Actually Suggests

    Think about the things in life we associate with creation, with sustaining, with bringing forth what wasn’t there before. Think about intuition — that knowing without being taught. Think about the way the earth itself works: cycles, gestation, seasons, birth.

    None of those things belong to one gender. But a lot of them — when you really look — feel more aligned with what we call feminine energy than anything else.

    Life doesn’t come from force. It comes from nurturing conditions. A seed doesn’t grow because you demand it. It grows because the right environment was held around it long enough. That’s not aggressive. That’s not dominant. That’s something else entirely.

    So I’m asking myself — why did the version of God I was handed look nothing like that?

    Why It’s Controversial (And Why That’s Telling)

    Here’s what I realized: the reason this conversation makes people uncomfortable isn’t really about God. It’s about control.

    When you define what God looks like, you define what power looks like. And for a very long time, in a lot of places, the people holding power needed God to look like them — to sound like them, to authorize them. Change the image, and you start pulling at a thread that runs through a lot of structures people have built their entire lives on.

    That’s not a small thing to question. I get why it rattles people. I was rattled too.

    But being rattled and being wrong aren’t the same thing. Sometimes you’re rattled because something is finally true enough to move you.

    Where I Actually Land

    I’m not here to tell you God is a woman. I’m also not here to tell you God isn’t. What I’m saying is that I walked into that conversation with a closed hand and left with an open one.

    If God is the source of everything — and I mean everything — then God has to contain everything. Every polarity. Every frequency. The full range. And if we’ve only ever talked about half of that, then maybe we’ve only ever understood half.

    That feels like a problem worth sitting with.

    Not arguing. Not defending. Just — sitting with it.

    Because the best questions aren’t the ones that give you answers. They’re the ones that show you how much wall you’d built around a door you didn’t even know was there.

  • Money as current: etymology, energy, and the psychology of flow

    **The word “currency” literally means “a flowing”** — from Latin *currentia*, the same root that gives us water currents and electrical currents. When the monetary sense entered English in **1729**, it crowned a metaphor already three centuries old: that money behaves like a fluid or energy circulating through a body. This is not poetry. From William Petty’s “money is the fat of the body politic” (1665) to Frederick Soddy’s thermodynamic critique of debt (1926) to modern econophysicists modeling wealth as a Boltzmann gas, serious thinkers have repeatedly concluded that money obeys flow-like laws. The psychological corollary is equally striking: people who treat money as static — to be hoarded, feared, or avoided — measurably accumulate less of it than those who treat it as something that moves through their lives. What follows traces this single idea through language, physics, and behavior, separating what is rigorously established from what is metaphor or wishful thinking.

    ## How a Latin verb for “running” became the word for money

    The Proto-Indo-European root **\*kers-** (“to run”) produced Latin *currere*, which seeded an extraordinary family of English words: *car, career, cargo, course, corridor, courier, curriculum, cursive, cursor, discourse, excursion, occur, recur* [Etymonline](https://www.etymonline.com/word/currency) — and *current*, *currency*. Welsh *carrog* (“torrent”) [Etymonline](https://www.etymonline.com/word/currency) preserves the original water-flow imagery. The English adjective *current* meant “running, flowing” by **c. 1300**; [Etymonline](https://www.etymonline.com/word/current) applied to a body of moving water by the **1550s**; [Etymonline](https://www.etymonline.com/word/current) applied to money “passing from one person to another” by the **late 15th century**. [Etymonline](https://www.etymonline.com/word/current) Then *currency* itself — borrowed from Medieval Latin *currentia*, [Wiktionary](https://en.wiktionary.org/wiki/currency) “a running” [Etymonline](https://www.etymonline.com/word/currency) — entered English in the **1650s** meaning “condition of flowing.” [Etymonline](https://www.etymonline.com/word/currency) Only in **1729** did it acquire its now-dominant sense: “**that which is current as a medium of exchange, money**.” [Etymonline](https://www.etymonline.com/word/currency) The word for money is, etymologically, **the flowing thing itself**.

    The same root produced the word for electrical *current* in the 19th century. So *monetary currency* and *electrical current* are not analogies — **they are the same word**, applied to different flows. Related terms preserve adjacent metaphors: *capital* descends from Latin *caput* (“head,” via livestock as wealth); *fiscal* from *fiscus* (“money bag, basket of twigs”); [Etymonline](https://www.etymonline.com/word/fiscal) *finance* from Old French *finer* (“to settle, to end”); [Etymonline](https://www.etymonline.com/word/finance) *economy* from Greek *oikonomia* (“household management”); [Etymonline](https://www.etymonline.com/word/economy) *money* itself from *Moneta*, an epithet of Juno whose Capitoline temple housed Rome’s mint. [Etymonline](https://www.etymonline.com/word/money) Across cultures, the flow metaphor recurs independently: Chinese **流通** (*liútōng*, “flow + pass through”) is the standard term for monetary circulation, [Panda Chinese](https://pandachinese.online/words/liutong/) [Yabla](https://chinese.yabla.com/chinese-english-pinyin-dictionary.php?define=liutong) with **流** meaning “to flow.”

    ## How blood circulation gave economics its operating metaphor

    The decisive moment was **1628**, when **William Harvey** published *De Motu Cordis*, demonstrating that blood circulates. Within a generation, this physiological insight was transposed onto money. **Hobbes’s *Leviathan*** (1651) described money as the commonwealth’s blood, [Springer](https://link.springer.com/chapter/10.1007/978-3-319-52815-1_4) “going round about, nourishing every part.” **William Petty**, an anatomist by training, wrote in 1665 that “**money is but the Fat of the Body-Politick, whereof too much doth often hinder its Agility, as too little makes it sick**” [En Academic](https://en-academic.com/dic.nsf/enwiki/202151) [Wikisource](https://en.wikisource.org/wiki/Petty’s_Place_in_the_History_of_Economic_Theory/5) — and pioneered the *velocity of money* concept that still anchors monetary economics. **François Quesnay**, court physician to Louis XV and leader of the Physiocrats, produced the **Tableau Économique** (1758) — the first formal diagram of macroeconomic circulation — explicitly modeling money flowing between economic classes “in the same mechanical way that blood flows between different organs.” [Wikipedia](https://en.wikipedia.org/wiki/Physiocracy) [New World Encyclopedia](https://www.newworldencyclopedia.org/entry/Fran%C3%A7ois_Quesnay) Adam Smith called money “the great wheel of circulation” and distinguished *fixed* from *circulating* capital. [Britannica](https://www.britannica.com/money/Francois-Quesnay) Keynes (1936) introduced **liquidity preference**, embedding fluid imagery so deeply that we now speak of *liquidity*, *cash flow* (first attested 1954), [Etymonline](https://www.etymonline.com/word/cash) *frozen assets*, *capital injections*, *trickle-down*, *pump priming*, *flooding markets*, and *capital flight* without noticing we are doing physics on a metaphor.

    ## The serious physics: thermodynamics, entropy, and econophysics

    The deeper claim — that money is *literally* a form of energy — has both rigorous and fanciful versions, and they should not be confused.

    **Frederick Soddy**, the 1921 Nobel laureate in Chemistry, made the most piercing argument. In *Wealth, Virtual Wealth and Debt* (1926), he distinguished **real wealth** (which obeys the second law of thermodynamics — buildings rust, oil burns, food spoils) from **virtual wealth** (money and debt, which obey only mathematics and grow exponentially via compound interest). The mismatch, Soddy argued, is the hidden engine of financial crises: claims compound while their physical backing decays. Dismissed as a crank in his lifetime, [Wikipedia](https://en.wikipedia.org/wiki/Frederick_Soddy) Soddy is now treated as the founding figure of ecological economics. **Nicholas Georgescu-Roegen** formalized the framework in *The Entropy Law and the Economic Process* (1971), arguing that economic activity is fundamentally the irreversible conversion of low-entropy resources into high-entropy waste. [Wikipedia](https://en.wikipedia.org/wiki/Nicholas_Georgescu-Roegen) His student **Herman Daly** showed that the standard “circular flow” diagram is *misplaced concreteness* — it omits the linear, one-way throughput of energy and matter that the circuit actually depends on.

    **Econophysics**, named by H. Eugene Stanley in 1995, applies statistical mechanics to economic data. In a landmark 2000 paper, **Victor Yakovenko** and Adrian Drăgulescu showed that because money is conserved in transactions, its equilibrium distribution among agents follows the **Boltzmann-Gibbs exponential law** — the same equation governing gas molecules — with average money per agent functioning as an “**effective monetary temperature**.” [Springer](https://link.springer.com/article/10.1007/s100510070114) Empirically, the bottom **97% of US income distributions** fits this exponential form; the top 3% follows a **Pareto power law**. [arXiv](https://arxiv.org/pdf/2307.02470) Trade between markets at different “temperatures” produces profit much as a heat engine extracts work from temperature differences. [Ucsb](https://online.kitp.ucsb.edu/online/colloq/yakovenko1/pdf/Yakovenko.pdf) Pink Floyd’s “*money, it’s a gas*” turns out to be approximately correct for 97% of us.

    Other serious frameworks include **Howard Odum’s emergy** (embodied solar energy as a unit of value); [Sustainability-directory](https://lifestyle.sustainability-directory.com/term/howard-t-odum/) the 1930s **Technocracy movement**, which proposed replacing dollars with **Energy Certificates** denominated in joules; [Brilliant Maps](https://brilliantmaps.com/the-technate-of-america/) and **Modern Monetary Theory’s** stock-flow consistent accounting, which uses Wynne Godley’s bathtub analogy — government spending fills the tub, taxes drain it, and the water level is the private sector’s net financial assets. Buckminster Fuller cut to the chase: “**Wealth is the product of energy times intelligence.**” [A-Z Quotes](https://www.azquotes.com/quote/890665) He defined a person’s wealth operationally as the number of days forward they can survive [Publish0x](https://www.publish0x.com/ijch-life-people-and-philosophy/ijch-dr-buckminster-fuller-and-my-favorite-definition-of-wea-xgvnn) — a measure in time and energy, not dollars.

    The popular and spiritual versions — Charles Eisenstein’s *Sacred Economics*, Lynne Twist’s *Soul of Money* (“**money is like water**”; stagnant money becomes “toxic”) [Thepathtoawesomeness](https://thepathtoawesomeness.com/the-soul-of-money/) — extend the same metaphor into ethics. They are philosophically coherent but make no falsifiable physical claims. The conflation of these registers with rigorous econophysics is the single most common error in popular “money is energy” discourse.

    ## Why scarcity is a cognitive trap, not just a feeling

    The most empirically robust finding in the psychology of money is that **scarcity itself degrades the decision-making capacity needed to escape it**. Sendhil Mullainathan and Eldar Shafir’s *Scarcity* (2013) and the underlying *Science* paper (Mani et al., 2013) showed that **inducing financial worry in low-income participants reduced fluid intelligence by the equivalent of ~13 IQ points** — larger than a sleepless night. [Harvard Magazine](https://www.harvardmagazine.com/social-sciences/the-science-of-scarcity) Indian sugarcane farmers performed measurably better on cognitive tests post-harvest (when flush) than pre-harvest (when poor) [Princeton University](https://www.princeton.edu/news/2013/08/29/poor-concentration-poverty-reduces-brainpower-needed-navigating-other-areas-life) — same individuals, different bandwidth. Scarcity “captures” attention, induces tunneling on the immediate shortfall, and shifts time orientation toward the present. [PubMed Central](https://pmc.ncbi.nlm.nih.gov/articles/PMC10910771/) This is not character weakness; it is cognitive load. The behavioral implication is profound: **a scarcity mindset is self-perpetuating**, because it consumes the executive function required to plan, negotiate, save, and invest.

    Carol Dweck’s growth/fixed mindset framework, while less robustly replicated than its popularity suggests, applies cleanly: declaring “I’m bad with money” functions as a fixed-mindset claim that becomes self-fulfilling. [Martha Lawton](https://www.marthalawton.com/marthasblog/2021/7/12/bad-with-money-fixed-mindset-carol-dweck) Stephen Covey’s *abundance vs. scarcity mentality* is normative rather than empirical, but it points to the same dynamic from a different angle: zero-sum thinking (“if you win, I lose”) [Sources of Insight](https://sourcesofinsight.com/integrity-maturity-and-abundance/) closes off the cooperative, opportunity-seeking behavior that actually generates wealth.

    ## The behavioral biases that quietly bleed wealth

    Half a century of behavioral economics has catalogued the specific cognitive errors through which people deflect money without realizing it. **Loss aversion** (Kahneman & Tversky, 1979) makes losses feel roughly twice as painful as equivalent gains, [Wikipedia](https://en.wikipedia.org/wiki/Loss_aversion) driving panic-selling and the disposition to hold losers too long. **Myopic loss aversion** (Benartzi & Thaler, 1995) means investors who check portfolios frequently take less productive risk — the equity premium puzzle. [Nicholasbarberis](https://nicholasbarberis.github.io/tt10b.pdf) [Wikipedia](https://en.wikipedia.org/wiki/Prospect_theory) **Mental accounting** causes people to maintain low-yield “savings” while carrying high-interest credit-card debt, because the dollars feel non-fungible. [Mwbpc](https://mwbpc.com/loss-aversion-and-mental-accounting-2/) **Present bias** and **hyperbolic discounting** undermine retirement saving; Thaler and Benartzi’s “Save More Tomorrow” program exploited the bias in reverse, committing future raises to savings and dramatically raising 401(k) participation. The **ostrich effect** (Karlsson, Loewenstein & Seppi, 2009) — avoiding financial information when markets fall [Arab Psychology](https://scales.arabpsychology.com/trm/ostrich-effect/) — afflicts about 79% of investors [Wikipedia](https://en.wikipedia.org/wiki/Ostrich_effect) and predicts worse retirement outcomes. Default options (auto-enrollment) capture status-quo bias for good. The cumulative cost of these biases, compounded over a working life, is enormous.

    ## Money scripts: the unconscious beliefs that predict net worth

    **Brad and Ted Klontz’s** money-script research (Klontz et al., *Journal of Financial Therapy*, 2011) is the most useful empirical framework for understanding why people unconsciously deflect wealth. Through the Klontz Money Script Inventory, they identified four belief patterns formed in childhood, often around “financial flashpoints”: [Financial Planning Association](https://www.financialplanningassociation.org/article/journal/NOV12-how-clients-money-scripts-predict-their-financial-behaviors)

    1. **Money avoidance** — “money is bad,” “rich people are greedy,” “I don’t deserve money.” **Significantly correlated with lower income and net worth.** This is the cluster most directly responsible for self-sabotage.
    2. **Money worship** — “more money will solve my problems.” Predicts overspending, compulsive buying, and credit-card debt. The most common pattern in Americans.
    3. **Money status** — self-worth equals net worth. [Superiorcu](https://www.superiorcu.org/blog/klontz) Drives conspicuous consumption and lower net worth despite often higher income.
    4. **Money vigilance** — frugal, watchful, private. **The only pattern positively associated with financial health**, though extreme vigilance produces anxiety. [Superiorcu](https://www.superiorcu.org/blog/klontz)

    A 2025 replication in a more diverse sample (n=2,686) found acceptable internal consistency but questioned the four-factor structure, [Springer](https://link.springer.com/article/10.1007/s10834-025-10055-7) so treat the categories as useful heuristics rather than fixed types. Nonetheless, the core finding holds: **avoidance, worship, and status scripts each independently predict worse financial outcomes**. [Financial Planning Association](https://www.financialplanningassociation.org/article/journal/NOV12-how-clients-money-scripts-predict-their-financial-behaviors)

    The famous misquote of 1 Timothy 6:10 — “money is the root of all evil” (the original specifies “the *love* of money”) — operates as a textbook avoidance script. So do “I’d be a sellout if I were rich,” guilt about earning more than parents, and the silent conviction that wealthy people are morally suspect. These beliefs cause people to undercharge, fail to negotiate, sabotage promotions, give money away compulsively, and avoid looking at their accounts. **Linda Babcock’s research** [PON – Program on Negotiation](https://www.pon.harvard.edu/daily/salary-negotiations/in-salary-negotiations-women-do-ask/) estimated that women who don’t negotiate forgo over $1 million in lifetime earnings — though her later work (with Bowles and Lai) documented a real social *backlash* against women who do negotiate, [PON – Program on Negotiation](https://www.pon.harvard.edu/daily/salary-negotiations/the-backlash-effect-for-women-negotiators-in-hollywood-and-beyond-nb/) so the issue is structural as well as psychological.

    ## What actually builds wealth: the unsexy evidence

    Thomas Stanley and William Danko’s 20-year survey research (*The Millionaire Next Door*, 1996) produced the single most consistent finding in personal-finance research: **wealth correlates with savings rate and frugality far more than with income**. Their “Prodigious Accumulators of Wealth” averaged ~20% savings rates, [Paminy](https://paminy.com/book-summary-the-millionaire-next-door/) lived well below their means, prioritized financial independence over status, and were disproportionately self-employed in unglamorous industries. High-income professionals — physicians, lawyers — frequently became “Under Accumulators of Wealth” [Wikipedia](https://en.wikipedia.org/wiki/The_Millionaire_Next_Door) through lifestyle inflation. Morgan Housel’s *Psychology of Money* synthesizes the same insight: [Affiancefinancial](https://www.affiancefinancial.com/news/morgan-housels-psychology-of-money) behavior dominates intelligence; [Booksummary](https://www.booksummary.xyz/2025/06/the-psychology-of-money-by-morgan.html) savings rate is the most controllable variable; [You Exec](https://youexec.com/resources/psychology-of-money) **roughly $81.5 billion of Warren Buffett’s $84.5 billion net worth was accumulated after age 65**, because compounding requires time more than brilliance. [REI Prime](https://reiprime.com/book-review/psychology-of-money-morgan-housel)

    Self-control matters, though less mythically than the marshmallow test suggested. Watts, Duncan & Quan’s 2018 replication found Mischel’s effect was about half the original size and largely explained by family background. [Sage Journals](https://journals.sagepub.com/doi/abs/10.1177/0956797618761661) But the broader Dunedin study (Moffitt et al., 2011, replicated 2023) confirmed that childhood self-control robustly predicts adult wealth, health, and life outcomes. **Bandura’s self-efficacy** — the belief that one *can* execute the necessary behaviors — is among the most replicated constructs in psychology and is a stronger predictor of financial behavior than financial literacy alone. Hershfield et al. (2011) showed that people exposed to age-progressed images of themselves saved measurably more for retirement: making the future self vivid changed present behavior.

    ## The Law of Attraction, separated from what actually works

    The metaphysical tradition — Wallace Wattles (*The Science of Getting Rich*, 1910) → Napoleon Hill (*Think and Grow Rich*, 1937) → Catherine Ponder → Rhonda Byrne (*The Secret*, 2006) — claims that thoughts emit vibrations that attract matching matter from the universe. **There is no empirical support for this literal claim**, and the misappropriation of quantum physics in popular versions is straightforwardly false (brain waves operate at 1–100 Hz, not the “40,000 Hz thought frequency” sometimes cited). The doctrine’s victim-blaming implications — that the poor, the sick, and the bereaved “attracted” their fate — are both ethically and empirically untenable.

    But several real psychological mechanisms are routinely credited to the Law of Attraction and *are* evidence-based. **Self-efficacy** (Bandura) genuinely predicts achievement. [APA](https://www.apa.org/research-practice/conduct-research/self-efficacy-human-agency) **Goal-setting and visualization** improve performance through attention and motivation. **Selective attention** — sometimes called the reticular activating system — really does cause people focused on a goal to notice opportunities they would otherwise miss. **Optimism and expectancy effects** are real, if bounded. The honest synthesis: positive expectation plus self-efficacy plus action produces measurable results; [Mental Health @ Home](https://mentalhealthathome.org/2018/09/18/is-law-of-attraction-real/) magical manifestation does not. Lynne Twist’s “sufficiency” framing — reframing the cultural lie of “not enough” [UpStartist](https://upstartist.tv/blog/the-soul-of-money-lynne-twist/) — is closer to C

  • The Architecture of Agency: Distinguishing Act, Action, and Performance in Philosophy and Jurisprudence

    Part I. Conceptual Foundations: Action, Act, and Agency

    The distinction between an ‘Act’ and ‘Action’ originates in the core debates of philosophical action theory, an interdisciplinary field that addresses fundamental questions regarding intentional behavior and agency. This theory forms the essential metaphysical bedrock upon which legal and critical theories of performance are built.

    1. The Metaphysics and Epistemology of Action

    Philosophical action theory is a complex area of thought intersecting epistemology, ethics, metaphysics, jurisprudence, and the philosophy of mind. Its central concern is defining what constitutes an action, thereby distinguishing it from mere physical events. Ever since Aristotle’s Nicomachean Ethics, philosophers have sought to isolate the quality of intentionality that transforms a bodily movement into a deliberate action.

    1.1 Defining Action Theory: Volition, Intentionality, and Causality

    The fundamental problem tackled by action theorists is the challenge of volition: identifying what connects an intention to a subsequent bodily movement. Ludwig Wittgenstein famously formulated this problem by asking: “What is left over if I subtract the fact that my arm goes up from the fact that I raise my arm?” The difference lies in the presence of an internal, volitional component — the Action. An action is often defined as an event caused by the agent’s internal mental states, such as desires, beliefs, motives, and deliberation. In this framework, the physical manifestation or bodily movement resulting from this internal process is the Act.

    The legal requirement for a “Voluntary Act” represents a crucial operational filter applied to this metaphysical problem. Since the judicial system cannot empirically verify the exact nature of the agent’s internal mental states, it must rely on observable proxies. The legal definition of the Act, which requires voluntary bodily movement, serves as a pragmatic attempt to simplify this complexity. By requiring voluntariness, the law aims to establish that the movement was an output of the agent’s conscious control, thus establishing a link back to the philosophical concept of Action.

    1.2 Agency, Control, and the Moral Agent

    The concept of agency is intrinsically linked to Action, denoting the exercise or manifestation of the capacity to act. Agency is a being’s inherent power to initiate action, and debates over its nature are crucial in determining moral responsibility and free will. The standard conception holds that agency is primarily characterized by intentional action, often explained by the causal role of mental states. Researchers distinguish between intention — the specific, verbalized influence guiding behavior — and intentionality, which can involve broader, contingency-shaped behavior where the consequences are clear but the specific mental construct is less defined.

    The necessary prerequisite for culpability in jurisprudence is the presupposition of agency. Philosophical judgments of moral responsibility are based on attributing certain powers and capacities to a person, viewing their subsequent behavior and its consequences as arising from the exercise of those powers. If an agent lacks the requisite control, as in cases of involuntary acts or automatism, the law often mandates an unqualified acquittal. Thus, the legal system implicitly incorporates philosophical Action Theory: the Act is punishable only if it is determined to be the product of culpable agency, evidenced by the element of voluntariness.

    Part II. Performance Theory: Embodiment, Presentation, and Repetition

    Performance theory offers a counterpoint to Action Theory by shifting the primary locus of meaning and relevance from the agent’s internal intention (Action) to the external presentation, context, and reception by an audience. Performance is structurally defined by its relational quality.

    2. Performance as Embodied Practice and Spectatorship

    Performance studies examines how individuals express themselves through action in contexts ranging from theatrical staging to cultural rituals and mundane social interactions. It blends insights from various disciplines to understand how these actions construct and reflect identity and societal norms.

    2.1 The Audience Factor and Meaning Creation

    A defining characteristic of Performance, as distinct from a solitary Act or Action, is the mandatory presence of an audience and a specific setting. Performance is an embodied practice involving the presentation or re-actualization of symbolic systems through living bodies. The essential difference between Action and Performance resides in the determination of success and meaning. An Action is successful when the agent fulfills their internal goal. A Performance, however, is validated externally. As sociologist Erving Goffman noted, when an individual “plays a part,” they implicitly request observers to “take seriously the impression that is fostered before them.” The success of the Performance lies not merely in the execution of the Act, but in the audience’s perception that “matters are what they appear to be.”

    2.2 Ritual, Dramaturgy, and the Power of Repetition

    Many performances, particularly rituals, rely heavily on repetition and structure to formalize their meaning and efficacy. Goffman’s dramaturgical analogy views social interaction as a constant process of impression management, where individuals utilize different facets of their personality in various social roles. Ritualistic behaviors often emerge in circumstances characterized by anxiety and are used to boost confidence, reduce uncertainty, and signal commitment to a belief system.

    Anthropological analysis, such as that provided by Victor Turner, breaks ritual enactment into stages: separation from ordinary life, a liminal period of transition and transformation, and reintegration back into society with a new status. The symbols and structured acts handled during a ritual are not passive representations; they possess transformative power, acting upon and changing the participants involved. The power of Performance, particularly in formalized rituals, lies in its iterative nature — the consistent repetition of actions solidifies shared meaning and reinforces social constructs. This phenomenon establishes the critical framework for performativity — the constitutive power of repeated, cited actions and discourses.

    Part III. The Critical Bridge: Performativity

    Performativity functions as the critical link between the discrete Act (physical movement) and the encompassing social framework (Performance), demonstrating how language and practice actively create the reality they appear only to describe.

    3. Speech Acts and Constitutive Language (Austin and Searle)

    The modern conceptualization of performativity begins with the philosophy of language, specifically J. L. Austin’s development of speech act theory.

    3.1 Performative Utterances vs. Constative Statements

    Austin introduced the concept of the performative utterance, challenging the positivist claim that all meaningful sentences must be descriptive statements capable of being evaluated as true or false. Performative utterances are sentences that, when spoken in suitable circumstances, perform or consummate an action rather than merely describing it. Examples include a judge pronouncing a verdict, an umpire calling a foul, or the exchange of vows in a wedding ceremony. Performative utterances are not evaluated by truth value but by felicity conditions — if performed correctly, they are “happy”; if flawed, they are “unhappy.”

    Austin and his successor John Searle refined the structure of the speech action into three distinct levels:

    • The Locutionary Act: The act of producing a meaningful expression — the physical utterance itself.
    • The Illocutionary Act: The act performed in saying something, constituting the social force of the utterance (e.g., asserting, warning, promising, or ruling).
    • The Perlocutionary Act: The effect achieved by saying something on the audience (e.g., persuading, alarming, or convincing).

    The illocutionary act serves as the closest philosophical analog to the legal Act of creating status or obligation. When a judge pronounces a verdict, the physical Act is the judge speaking (locutionary), and the Action is the judge’s intention to rule. However, the legal reality — the fact that the defendant is now convicted or acquitted — is the direct result of the illocutionary force. This explains the stringent formalism of legal language, as its efficacy is dependent on strict adherence to conventional procedures.

    4. Performativity as Social Citation (Butler)

    While Austin focused on individual utterances, later critical theory — most notably that of Judith Butler — expanded performativity to describe the repetitive, societal mechanisms that constitute reality and subjectivity.

    4.1 Shifting the Locus of Agency: Citation and Compulsory Norms

    Butler’s understanding of performativity shifts the focus away from a spontaneous, intentional utterance toward the deployment of ontological norms through continuous discourse, utilizing a concept of “citation” derived from Derrida. Pre-existing social conditions and norms — such as gender or property frameworks — often exceed and precede the contingent immediacy of the present moment of utterance. In this model, agency is not viewed as an inherent, inborn property of the individual but rather as a possibility that arises integral to the performative practice of citing and challenging the regulatory norms.

    The systemic nature of the law presents a complex, dualistic view of volition that relies on both the Austinian and Butlerian models simultaneously. Jurisprudence uses Austin’s model for assessing individual liability. However, the legal institution itself operates as a system of Butlerian performativity. The fundamental structures of property, marriage, and corporate personhood are not spontaneously created but are the results of centuries of reiterated legislative Acts, judicial rulings, and ceremonial enactments.

    Part IV. Jurisprudential Expression and Distinction

    In legal discourse, the concepts of Act and Performance are operationally separated and applied to distinct spheres of law, reflecting different concerns regarding individual culpability versus relational obligation.

    5. The Act in Criminal and Tort Law: Actus Reus

    5.1 Actus Reus: The Voluntary Act Requirement

    The term actus reus refers to the physical elements of a crime required by statute, comprising the external, observable conduct or outcome. This is distinct and separate from mens rea, the mental state or criminal intent element (the Action). Critically, the actus reus must be a voluntary affirmative act or a legally proscribed omission. If a defendant acts on reflex, during an epileptic seizure, or under conditions of non-insane automatism, the conduct does not satisfy the actus reus requirement. The stringent demand for voluntariness ensures that criminal punishment is only applied where there has been a culpable exercise of agency.

    5.2 Omissions and Contractual Duty

    The actus reus requirement can also be satisfied by an omission — a failure to act — but only when the individual was under a pre-existing legal duty to act. Such duties can arise from statute, special status relationships (like parental responsibilities), voluntary assumption of care, or from a contract. A failure of Contractual Performance (a breach of duty established in private law) can, in specific contexts, satisfy the definition of a criminal omission. This reveals the porous boundary between private law obligations — which are fundamentally concerned with Performance — and public law responsibilities.

    6. Performance in Contract and Equity Law

    6.1 Performance as Obligation Fulfillment

    Contract law governs obligations that arise solely from the voluntary agreement of the parties, a source fundamentally different from the duties imposed by law found in tort. Performance, in this context, refers to the Act of carrying out or fulfilling the duties and obligations stipulated in the agreement. The legal system assesses Performance based on the fulfillment of the agreed-upon terms, typically requiring a standard of substantial performance rather than perfect execution. Contractual Performance is analyzed as mechanical execution largely decoupled from internal volition once the commitment is made.

    6.2 The Equitable Remedy of Specific Performance

    In cases of contract breach, an equitable remedy known as Specific Performance is available, whereby a court issues an order requiring the breaching party to complete the agreed-upon acts and obligations. Specific Performance is a discretionary remedy, reserved for situations where monetary damages are inadequate to compensate the injured party, typically involving unique or irreplaceable subject matter such as real property or rare chattels.

    The court order for Specific Performance highlights a profound paradox regarding agency and volition. The court’s ruling overrides the breaching party’s current volitional Action. The law’s historical aversion to compelling personal service contracts — such as forcing an artist to paint a specific portrait — acknowledges a practical limit on this compulsion, implicitly recognizing that some acts cannot be successfully compelled without the actor’s internal volition.

    6.3 Performance vs. Damages: The Efficient Breach Debate

    The debate over the routine availability of Specific Performance versus the standard award of damages encapsulates a jurisprudential tension over the inherent value of the promised Act. Anglo-American contract law often favors awarding expectation damages, an approach that has evolved into the Efficient Breach Theory. This theory holds that a party should be encouraged to breach a contract if their profit from the breach exceeds the loss incurred by the promisee. This preference for damages reflects a legal tendency to devalue the specific physical Act or Performance itself, treating it as a fungible commodity measurable in monetary terms.

    7. Law as Performance and Performativity

    Beyond the individual actions of litigants, the legal institution operates as a system built on both Performance and Performativity, utilizing ritual and display to establish and maintain its authority. Legal processes are inherently public and ritualistic. The courtroom, with its formalized roles and procedures, functions as a form of social metatheatre. The efficacy of a legal Act — such as legislation or a judge’s constitutive ruling — is entirely dependent on the faithful execution of the surrounding ceremonial and procedural ritual. A judge’s utterance of a verdict only achieves “happiness” if performed by the correct authority, in the correct setting, adhering to stringent procedural expectations.

    Part V. Conclusion and Interdisciplinary Synthesis

    8. A Nuanced Taxonomy of Act, Action, and Performance

    Action theory establishes the Action as the internal, intentional, and volitional causal event originating with the agent. The Act is the discrete, observable physical manifestation or bodily movement resulting from the Action. Performance is the external, often stylized or repetitive execution of duties, evaluated by an audience or a context based on fulfillment and impression management. Finally, Performativity describes the capacity of language and discourse, through citation and repetition, to constitute reality and define subjective frameworks.

    The legal system strategically operationalizes these concepts in disparate domains. Criminal Law focuses on the Act as the voluntary physical proxy for internal, culpable Action (mens rea). Contract Law focuses on the fulfillment of obligations established by an initial, voluntary Action, prioritizing the completion of the promised Performance. Constitutional and Judicial Law depends on constitutive language that creates social reality, buttressed by procedural and ceremonial Performance.

    8.2 Implications for Moral and Legal Responsibility

    The differentiation of these concepts carries significant implications for attributing responsibility. Moral responsibility is profoundly tied to Action and the agent’s capacity for control. Criminal law honors this by demanding both Action (mens rea) and the voluntary Act (actus reus). However, legal responsibility in relational contexts, particularly contract law, is tied to the successful Performance — the outcome of the initial autonomous Action. The law’s willingness to compel Specific Performance demonstrates a pragmatic shift: once the initial voluntary Action establishing the duty is complete, the subsequent individual Act is rendered involuntary if necessary to protect the promisee’s relational expectations.

    Finally, social and political responsibility often emerges through the critical lens of Performativity. The collective responsibility for widespread harm must be understood not merely as the summation of individual actions but as the structural consequence of systemic Performance and the regulatory norms established by Performativity. A comprehensive understanding of jurisprudence therefore requires acknowledging the irreducible differences among the Act, Action, and Performance, and recognizing how the law selectively employs or subordinates these concepts to serve competing ethical and practical goals.

  • DNA Testing vs. Marriage

    Cast your vote on mandatory paternity testing at birth

    The Paternalistic Paradox: An Exhaustive Analysis of Regulator Conflict, Corporate Influence, and Medical Autonomy in U.S. Health Policy

    I. Introduction: Framing the Tension Between Endorsement and Restriction

    The premise that the United States government system exhibits an “absurd” contradiction—granting significant regulatory legitimacy (“full faith and credit”) to commercially developed treatments while simultaneously limiting individual medical choices—identifies a core tension within modern U.S. health governance. This contradiction is not merely administrative inefficiency; it reflects a deep ethical and institutional conflict rooted in the delegation of state authority, the influence of private capital, and the perennial struggle between collective public welfare and personal medical autonomy.
    The critique centers on why commercial actors (“strangers”) are granted regulatory trust to define approved medicine, while citizens (“the people”) face complex regulatory and economic barriers when attempting to exercise medical discretion. This report rigorously dissects this policy environment, treating the assertion of “absurdity” not as an emotional claim but as a description of a compromised policy mechanism wherein objectivity is tainted and paternalism is inconsistently applied.

    A. Deconstructing the User’s Assertion: The Concept of “Absurdity” in Policy

    The assertion rests on the observation that the legislative and regulatory branches utilize state power in two seemingly contradictory ways. On one hand, they empower private companies to develop and sell “science projects for symptoms of disease,” lending these products the legitimacy of federal approval. On the other, these same representatives employ restrictive policies to “dictate what the people are able to choose for themselves.”
    From a scholarly perspective, the legitimacy of the U.S. regulatory state emerged historically from the necessity of consumer protection against fraudulent claims and unsafe products. The government’s role is inherently paternalistic: it restricts market access to unproven or dangerous items to protect the individual’s health and safety. The perceived “absurdity” arises when this paternalistic justification is undermined by evidence that the endorsement process itself may be influenced by the profit motives of the regulated entities, thereby transforming protective governance into a system that appears to primarily shield favored commercial interests.

    B. Defining the Dual Mandates: Safety/Efficacy vs. Public Health/Liberty

    The policy conflict is encapsulated by two distinct, sometimes colliding, regulatory objectives:
    Endorsement (Conventional Standard): Federal agencies, particularly the Food and Drug Administration (FDA), are tasked with ensuring that approved items (drugs, devices) demonstrate sufficient safety and efficacy, meaning their benefits must demonstrably outweigh potential risks. This process provides the essential scientific legitimacy required for commercial distribution and clinical recommendation.
    Restriction (Paternalistic Standard): Public health policy, supported by state police power, aims to protect the collective well-being. This objective frequently necessitates limitations on individual liberty, such as mandatory vaccinations or restrictions on access to high-risk substances.
    The central legal and ethical tension lies between the moral imperative of autonomy—defined as self-rule free from controlling interference and predicated on meaningful choice —and the political goal of public well-being, where the collective health interest may supersede individual preference. A nuanced analysis must determine if current policy strikes a justifiable balance or if, as the user suggests, the mechanism of endorsement has been sufficiently corrupted to invalidate the ensuing restrictions.
    II. The Mechanism of Endorsement: Granting “Full Faith and Credit” to Conventional Medicine
    The legitimacy conferred upon drugs, devices, and standardized treatments is built upon a multi-layered regulatory architecture involving sophisticated scientific review and governmental coordination. This rigorous process is the foundation upon which public and institutional trust rests.
    A. The Regulatory Gateway: FDA, CDC, and HHS Roles in Policy Legitimation
    The primary source of government-sanctioned medical legitimacy flows from the U.S. Food and Drug Administration (FDA), an agency under the Department of Health and Human Services (HHS). The process for legitimizing a drug or medical device is exhaustive: it begins with product development, followed by animal testing to assess toxicity, and an Investigational New Drug (IND) application submitted to the FDA. If approved, the product enters multi-phase clinical trials involving human subjects. The culmination is the New Drug Application (NDA) review, facility inspection, and finally, approval, coupled with mandatory post-marketing safety monitoring. This regulatory seal of approval signifies a determination that the product’s benefits outweigh its potential risks.
    The broader health policy framework is managed by the Office of Health Policy (HP) within HHS, which coordinates and informs departmental leadership on health issues. HP’s mission bridges Departmental programs, the private sector, and the research community by conducting policy and economic analysis, assisting in regulation and budget review, and coordinating research related to health policy. This ensures that FDA-approved products and recommendations are smoothly integrated into state and local activities.
    Furthermore, Congress plays a critical oversight role. Congressional committees, such as those related to Appropriations and Commerce, Science and Transportation, maintain health jurisdiction, allocate discretionary spending (often through the Labor-HHS-Education spending bill), and handle policies related to consumer protection and health technology. Congressional action directly dictates the resources and policy priorities of the regulatory agencies.
    B. Transparency, Expertise, and the Role of Scientific Panels
    The justification for the government’s trust in approved medicine lies in the presumed rigor and objectivity of the scientific review.
    The process is inherently reliant on external experts. The FDA regularly convenes independent expert panels to review the latest scientific evidence, evaluate potential health risks, and offer recommendations for regulatory action. These advisory committees, and analogous panels used by organizations like the Veterans Health Administration (VA), are critical for synthesizing existing knowledge and developing context-sensitive, evidence-based practices.
    However, the analysis of this process reveals a structural tension regarding the integrity of the endorsement. The stringent FDA clearance process—for instance, estimates show that less than 30% of submissions to the Center for Devices and Radiological Health (CDRH) were successfully cleared in recent years —is meant to demonstrate high standards and build public confidence. This rigor, however, does not eliminate risk. The complexity of modern products, such as AI-integrated medical devices, has already been associated with a higher probability of recalls. The regulatory seal, while based on substantial scientific review, is therefore vulnerable, signifying that the “full faith” conferred by the government is given to a system that, while strict, is demonstrably fallible.
    This reliance on a rigorous, yet imperfect, scientific assessment directly affects the application of the legal doctrine of informed consent. This principle requires healthcare providers to ensure patients are fully informed about a treatment’s risks, benefits, and alternatives before agreeing to proceed. Informed consent is designed to be the clinical safeguard against undue coercion, ensuring that self-rule in medical decision-making is meaningful. If the information provided by the regulatory system—which defines the risks and benefits summarized in the FDA drug label —is objectively sound and untainted by external bias, then informed consent functions correctly. If, however, the regulatory endorsement is compromised by conflicts of interest or corporate influence, the factual basis of the product’s claimed integrity is corrupted, making the patient’s consent potentially less meaningful. The validity of the restriction mechanism hinges entirely on the perceived integrity of the endorsement mechanism.
    III. Systemic Vulnerability: Corporate Capture and Conflicts of Interest
    The integrity of the endorsement process, which serves as the legal and moral foundation for subsequent restrictions on choice, is demonstrably vulnerable to corporate influence. This critical assessment of industry ties forms the basis for the user’s argument regarding the system’s “absurdity.”
    A. The Influence of Pharmaceutical Lobbying on Legislation and Pricing
    Pharmaceutical companies exert influence over policymaking through a process termed “corporate capture,” where private interests prioritize profits over public well-being by exerting undue influence over policymakers. The tactics used are extensive, including direct lobbying, campaign contributions, funding specific medical research, and providing financial support to nominally “independent” organizations, such as certain patient advocacy groups.
    This influence has tangible, detrimental effects on legislation and public health costs. A landmark example is the Medicare Modernization Act (MMA) of 2003, where intense lobbying successfully ensured the exclusion of government negotiation for drug prices, a policy decision that significantly contributes to the high cost of prescription medications in the U.S.. Similarly, during the debates surrounding the Affordable Care Act (ACA), the industry lobbied actively and successfully avoided more stringent pricing regulations. Even legislation aimed at public safety, such as the Combatting Opioid Epidemic Act of 2018, was influenced by pharmaceutical lobbying, raising concerns about the final bill’s efficacy.
    The consequences of this close relationship extend beyond healthcare policy. The rising costs of prescription drugs, fueled by limited pricing regulation, necessitate spending cuts in unrelated areas of local government, such as education and infrastructure, to cover health care expenditures. This structural phenomenon demonstrates how the prioritizing of industry profit effectively skews the public interest at multiple levels of governance.
    B. Conflicts of Interest in the Advisory Apparatus
    The regulatory seal of approval is often determined by expert advisory committees, which must maintain scientific impartiality. However, regulatory frameworks acknowledge the risks associated with financial relationships. A conflict of interest (COI) arises when an individual serving on an FDA Advisory Committee has financial interests that could be impacted by their work.
    Federal agencies, including the FDA and the Centers for Medicare & Medicaid Services (CMS), have policies requiring disclosure and management of such conflicts. For instance, CMS requires standards of conduct regarding significant financial interests, defining this broadly to include salary, equity interest (stocks/options), and intellectual property rights (patents/royalties), though there are exemptions for income from advisory committees for non-profit entities.
    The FDA is authorized to grant waivers allowing individuals with potentially conflicting financial interests to participate in meetings, provided the agency determines that the need for the expert’s service outweighs the potential for conflict. This statutory allowance, while intended to ensure access to essential expertise, frequently draws public and Congressional scrutiny regarding transparency and the potential for compromised decision-making.
    Empirical data confirms a correlation between specific financial ties and voting outcomes. An analysis of FDA Center for Drug Evaluation and Research advisory committee members indicates a pro-sponsor voting bias among members who have exclusive financial relationships with the sponsoring firm—for example, serving on advisory boards solely for the firm under review. Conversely, members with broader financial relationships across multiple firms did not, on average, demonstrate a general pro-industry bias. This points to a nuanced vulnerability: the direct, nonexclusive relationship is the primary factor undermining the perception of objectivity.
    The concern over compromised objectivity extends to public input sessions. Researchers reviewing FDA Human Drug Advisory Committee meetings between 2015 and 2023 found that 43% of public speakers disclosed a conflict of interest, typically involving financial support from a drug manufacturer. These speakers with a COI were 11% more likely to support drug approval than those without conflicts. This data suggests that the public hearing sessions, intended to gather diverse perspectives, can be functionally skewed by industry-backed advocacy, further strengthening the impression that commercial interests dominate the endorsement dialogue.
    The potential for compromised regulatory science, driven by industry ties, has been cited as a factor contributing to catastrophic policy failures, such as the initial approval pathways that fueled the opioid crisis. High-profile, controversial drug approvals, such as Aduhelm for Alzheimer’s disease in 2021 despite conflicting clinical trial results, reinforce the public perception that regulatory bodies sometimes prioritize political or industry pressure over robust scientific consensus.
    Table 1: Quantification of FDA Advisory Committee Conflicts of Interest and Bias
    
    The crucial implication of these vulnerabilities is that the government’s justification for restricting individual choice—the classic paternalistic claim of protecting the public from unknown dangers—is severely weakened. If the process used to distinguish “safe and effective” treatments (those endorsed) from “dangerous alternatives” (those restricted) is polluted by institutional bias and corporate interests , then the moral and scientific authority of the state to dictate choices begins to collapse. The structural contradiction is realized: the source of the regulatory authority (objective science) is demonstrably captured by the very commercial interests it is meant to regulate, thereby invalidating its moral claim to restrict subsequent citizen choice.
    IV. The Mechanism of Restriction: Dictating Personal Medical Choices
    The second part of the user’s paradox—the government’s role in dictating or limiting individual medical choices—is supported by enduring constitutional doctrines that grant the state expansive power to protect the public health.
    A. Constitutional Authority: State Police Power and Public Health Mandates
    The legal basis for state restriction is the police power, which allows states to regulate for the public health and safety of their citizens. This authority was affirmed in the landmark 1905 Supreme Court case, Jacobson v. Massachusetts. The Court held that a Massachusetts law allowing cities to mandate smallpox vaccination was a legitimate exercise of the state’s police power. Justice John Marshall Harlan, writing for the majority, emphasized the principle of “self-defense” and “paramount necessity,” affirming that a community has the right to protect itself against an epidemic. This doctrine has been frequently cited during subsequent public health crises, supporting mandatory public health measures such as mask mandates and shelter-in-place orders.
    However, this collective power is balanced against individual liberties. The constitutional right of a competent patient to refuse life-sustaining medical treatment is protected under the 14th Amendment’s Due Process clause. The Supreme Court upheld this right in Cruzan v. Director, Missouri Department of Health (1990), confirming that competent patients possess the autonomy to reject or discontinue medical interventions. This tension between the state’s duty to compel compliance for the collective good and the individual’s right to self-determination defines the battleground of medical liberty.
    The legal power to restrict unapproved medicine also traces back to state authority to regulate the practice of medicine. In Dent v. West Virginia (1888), the Supreme Court upheld the state’s authority to license physicians, justifying the action as necessary to secure the public “against the consequences of ignorance and incapacity, as well as of deception and fraud”. This provides the foundational legal justification for limiting access to non-conventional or unlicensed practitioners.
    Table 2: Key U.S. Supreme Court Precedents on State Power and Medical Autonomy
    
    B. The Limits of Choice: Regulation of Non-Conventional Therapies
    The power to define the “practice of medicine” grants states the ability to restrict access to complementary and alternative medicine (CAM). State medical licensing statutes typically define practice by activities like diagnosis, treatment, and prescribing in connection with disease. Courts have interpreted these statutes broadly, upholding prohibitions against unlicensed CAM practitioners, such as acupuncturists, even if their “philosophy, practice and technique” differ from conventional allopathic medicine. These state-level restrictions form a significant legal barrier to medical choice in the U.S.
    Federally, the FDA exercises its authority to restrict substances posing a public threat, even those derived from natural sources, if they are concentrated and present a potential for abuse. For example, the FDA has recommended scheduling actions under the Controlled Substances Act (CSA) to control 7-hydroxymitragynine (7-OH), a byproduct of the kratom plant, recognizing its potential for abuse as an opioid. This action demonstrates the federal government’s direct power to restrict substances that, while potentially sold as supplements, function outside the regulated pharmaceutical market and pose a public safety risk.
    Regulation of most dietary supplements, however, is handled under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which places the responsibility for ensuring safety and labeling on manufacturers and distributors. The FDA retains the authority to take action only after an adulterated or misbranded product reaches the market. This reactive regulatory stance, compared to the proactive requirement for drug approval, creates a policy gap. This difference often leads to conflicts, as states seeking stricter requirements for supplements may face challenges based on the Supremacy and Commerce Clauses of the U.S. Constitution.
    C. Paternalism and Access: Limitations on Approved Treatments
    The restrictions on individual choice are often economic, rather than purely legal prohibitions. This is visible in the disconnect between scientific endorsement (FDA approval) and practical access (insurance coverage).
    While FDA approval means a drug is safe and effective for its approved indication , it does not guarantee insurance coverage. Furthermore, physicians may legally prescribe FDA-approved drugs for unapproved, or “off-label,” uses when they judge it medically appropriate for their patient. This clinical flexibility allows for innovative treatment, particularly in areas like cancer care, where laws sometimes mandate coverage for medically appropriate off-label uses referenced in major journals.
    However, the real limitation on choice comes from the payers. Health insurance companies, including the largest payer, the Centers for Medicare & Medicaid Services (CMS), frequently restrict access to novel therapies even after FDA approval through mechanisms like prior authorization or step therapy. This means that while a treatment may be scientifically endorsed by the government and legally permitted b